Stephanie Chu

Stephanie Chu currently serves as the Director of Project and Portfolio Management at Crinetics Pharmaceuticals since August 2025. Prior to this role, Stephanie held senior and director-level positions in program management at FibroGen, Inc. from June 2022 to May 2025, and at Amgen from February 2017 to May 2022. Earlier experience includes roles at the Los Angeles County Department of Public Social Services and C&C Biopharma, as well as various research positions at Ambrx and The Scripps Research Institute. Stephanie holds an M.B.A. in Finance and Marketing from the University of Rochester - Simon Business School and a Bachelor’s Degree in Molecular Biology from UC San Diego. Additional professional development includes training at Aalto University and UC San Diego Extended Studies.